The Philolexian Society of Columbia University
M. Kazim Panjwani
Vital
- Full name
- M. Kazim Panjwani
Columbia & the Society
- Columbia
- Class of 2011 (Columbia College)
Works (8)
- 2016 “Feasibility and Safety of RNA-Transfected CD20-Specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma” · Molecular Therapy
- 2018 “Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas” · Molecular Therapy – Oncolytics
- 2020 “Establishing a Model System for Evaluating CAR T Cell Therapy Using Dogs with Spontaneous Diffuse Large B Cell Lymphoma” · Oncoimmunology
- 2021 “Human Cytomegalovirus Expands a CD8+ T Cell Population with Loss of BCL11B Expression and Gain of NK Cell Identity” · Science Immunology
- 2021 “Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset” · The Journal of Immunology
- 2023 “Immune Escape after Allogeneic Hematopoietic Cell Transplantation in Pediatric Acute Myeloid Leukemia” · Blood Advances
- 2024 “Polygenic Polymorphism Is Associated with NKG2A Repertoire and Influences Lymphocyte Phenotype and Function” · Blood Advances
- 2024 “Single-Cell Profiling Aligns CD56bright and Cytomegalovirus-Induced Adaptive Natural Killer Cells to a Naïve-Memory Relationship” · Frontiers in Immunology
Primary sources
The Foundation's research archive
other_printed (philolexian roll of members 1963-2021)
struck through by hand · Confidence: CERTAIN
Community-maintained record
Spot an error or a missing citation?
This page lists only facts the Foundation can source. If you find an error, a missing work, or a citation we should carry, please email corrections@philolexianfoundation.org or use our contact form.